ITP - Immune Thrombocytopenia

Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia

OM336 in Autoimmune Cytopenias

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study

Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura

"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia

Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia

Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure

Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)

Explore the Relationship Between Platelet Count and Bleeding Score in ITP

Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura

Immune Markers in Pediatric ITP on Second Line Therapy

High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial